Atlas Trials

Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer

Clinical trial NCT04044430 · TERMINATED

Trial details

NCT number
NCT04044430
Sponsor
University of California, San Francisco
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal CarcinomaMetastatic Rectal AdenocarcinomaStage III Colon CancerStage III Colorectal CancerStage III Rectal CancerStage IIIA Colon CancerStage IIIA Colorectal CancerStage IIIA Rectal CancerStage IIIB Colon CancerStage IIIB Colorectal Cancer
Start date
2020-08-31
Primary completion
2022-07-31
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.